| Hem/Oncs | APPs | |
|---|---|---|
| Diagnose VOD | 24% RI (p < 0.001); post-CG 88% | 53% RI (p < 0.001); post-CG 49% |
| Baltimore Criteria | 1% RI (p < 0.103); post-CG 77% | 11% RI (p < 0.103); post-CG 50% |
| Seattle Criteria | 5% RI (p < 0.140); post-CG 69% | 11% RI (p < 0.140); post-CG 41% |
| Treat VOD | ||
| Order defibrotide | 103% RI (p < 0.001); post-CG 63% | 209% RI (p < 0.001); post-CG 34% |
| Order intravenous fluids | 116% RI (p < 0.001); post-CG 54% | 83% RI (p < 0.001); post-CG 44% |
| Continue ursodiol | 11% RI (p = 0.015); post-CG 91% | 8% RI (p < 0.001); post-CG 90% |
| RI = relative improvement pre-CG to post-CG | ||
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.